The Roles of Cost and Recommendations in Driving Vaccine Take-Up: Evidence from the Herpes Zoster Vaccine for Shingles Prevention

IF 3.1 2区经济学 Q1 ECONOMICS

American Journal of Health Economics Pub Date : 2023-10-09 DOI:10.1086/723541

Brandyn Churchill, Laura Henkhaus

引用次数: 0

Abstract

Previous articleNext article No AccessThe Roles of Cost and Recommendations in Driving Vaccine Take-Up: Evidence from the Herpes Zoster Vaccine for Shingles PreventionBrandyn Churchill and Laura HenkhausBrandyn Churchill Search for more articles by this author and Laura Henkhaus Search for more articles by this author PDFPDF PLUS Add to favoritesDownload CitationTrack CitationsPermissionsReprints Share onFacebookTwitterLinkedInRedditEmailPrint SectionsMoreDetailsFiguresReferencesCited by American Journal of Health Economics Just Accepted Published for the American Society of Health Economists (ASHEcon) Article DOIhttps://doi.org/10.1086/723541 Views: 12Total views on this site HistoryAccepted September 20, 2022 PDF download Crossref reports no articles citing this article.

查看原文本刊更多论文

成本和建议在推动疫苗接种中的作用:来自带状疱疹疫苗预防带状疱疹的证据

成本和建议在推动疫苗接种率中的作用:来自带状疱疹疫苗预防带状疱疹的证据brandyn Churchill和Laura henkausbrandyn Churchill搜索本作者和Laura henkausbrandyn Churchill的更多文章搜索本作者的更多文章PDFPDF PLUS添加到收藏列表下载引文跟踪引文missions转载分享在facebook twitter linkedinredditemailprint sectionsdetailsfigures参考文献引用美国卫生经济学杂志刚刚接受出版为美国卫生经济学家学会(ASHEcon)文章doi: https://doi.org/10.1086/723541浏览量:12本网站总浏览量历史接受2022年9月20日PDF下载Crossref报告没有引用本文的文章。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Health Economics Multiple-

CiteScore

4.30

自引率

2.70%

发文量

期刊介绍： The American Journal of Health Economics (AJHE) provides a forum for the in-depth analysis of health care markets and individual health behaviors. The articles appearing in AJHE are authored by scholars from universities, private research organizations, government, and industry. Subjects of interest include competition among private insurers, hospitals, and physicians; impacts of public insurance programs, including the Affordable Care Act; pharmaceutical innovation and regulation; medical device supply; the rise of obesity and its consequences; the influence and growth of aging populations; and much more.